HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and ...

Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Zee Laboratories supplies medicines to government hospitals and institutions such as AIIMS, as well as to central and state ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...